Home >> Research Area >>Others>>Nampt>> GMX1778 (CHS828)

GMX1778 (CHS828)

NAMPT inhibitor CAS# 200484-11-3

GMX1778 (CHS828)

Catalog No. BCC6527----Order now to get a substantial discount!

Product Name & Size Price Stock
GMX1778 (CHS828): 5mg $35 In Stock
GMX1778 (CHS828): 10mg Please Inquire In Stock
GMX1778 (CHS828): 20mg Please Inquire Please Inquire
GMX1778 (CHS828): 50mg Please Inquire Please Inquire
GMX1778 (CHS828): 100mg Please Inquire Please Inquire
GMX1778 (CHS828): 200mg Please Inquire Please Inquire
GMX1778 (CHS828): 500mg Please Inquire Please Inquire
GMX1778 (CHS828): 1000mg Please Inquire Please Inquire
Related Products
  • PD 166793

    Catalog No.:BCC2376
    CAS No.:199850-67-4
  • CP 471474

    Catalog No.:BCC2373
    CAS No.:210755-45-6
  • ONO 4817

    Catalog No.:BCC2375
    CAS No.:223472-31-9
  • UK 370106

    Catalog No.:BCC2379
    CAS No.:230961-21-4
  • Ursolic acid

    Catalog No.:BCN4327
    CAS No.:77-52-1
  • ARP 101

    Catalog No.:BCC2371
    CAS No.:849773-63-3

Quality Control of GMX1778 (CHS828)

Number of papers citing our products

Chemical structure

GMX1778 (CHS828)

3D structure

Chemical Properties of GMX1778 (CHS828)

Cas No. 200484-11-3 SDF Download SDF
PubChem ID 148198 Appearance Powder
Formula C19H22ClN5O M.Wt 371.86
Type of Compound N/A Storage Desiccate at -20°C
Solubility DMSO : ≥ 39 mg/mL (104.88 mM)
*"≥" means soluble, but saturation unknown.
Chemical Name 2-[6-(4-chlorophenoxy)hexyl]-1-cyano-3-pyridin-4-ylguanidine
SMILES C1=CC(=CC=C1OCCCCCCN=C(NC#N)NC2=CC=NC=C2)Cl
Standard InChIKey BOIPLTNGIAPDBY-UHFFFAOYSA-N
Standard InChI InChI=1S/C19H22ClN5O/c20-16-5-7-18(8-6-16)26-14-4-2-1-3-11-23-19(24-15-21)25-17-9-12-22-13-10-17/h5-10,12-13H,1-4,11,14H2,(H2,22,23,24,25)
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of GMX1778 (CHS828)

DescriptionGMX1778(CHS-828) is a potent inhibitor of NAD+ biosynthesis enzyme NAMPT with IC50 <25 nM. IC50 value: < 25 nM [1] Target: NAMPT inhibitor in vitro: The phosphoribosyltransferase activity of recombinant NAMPT was sensitive to inhibition by GMX1778 (IC50 < 25 nM) whereas the adenyltransferase activity of recombinant NMNAT1 was not. The Kd of recombinant NAMPT for GMX1778 labeled with a fluorescent tag (GMX1778-Alexa Fluor) was 120 nM. Overexpression of wild-type NAMPT was able to maintain a certain level of NAD+ under conditions of challenge with 3 nM GMX1778, but this effect was lost when cells were exposed to 300 nM GMX1778 [1]. GMX1778 increases intracellular ROS in cancer cells by elevating the superoxide level while decreasing the intracellular NAD(+) level. Notably, GMX1778 treatment does not induce ROS in normal cells. GMX1778-induced ROS can be diminished by adding nicotinic acid (NA) in a NA phosphoribosyltransferase 1 (NAPRT1)-dependent manner [2]. in vivo: A 4-h iv infusion of NA (120 mg/kg of body weight) did not adversely affect the antitumor activity of a 24-h iv infusion of GMX1777 at a dose of 150 mg/kg or 650 mg/kg in the NAPRT1-deficient xenograft experiments. GMX1777 at 650 mg/kg is above the maximum tolerated dose. The administration of NA as a 4-h iv infusion immediately following treatment with 750 mg/kg GMX1777 reduced the mortality associated with toxic doses of GMX1777 [1].

References:
[1]. Watson M, et al. The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors. Mol Cell Biol. 2009 Nov;29(21):5872-88. [2]. Cerna D, et al. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner

GMX1778 (CHS828) Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

GMX1778 (CHS828) Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of GMX1778 (CHS828)

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.6892 mL 13.4459 mL 26.8918 mL 53.7837 mL 67.2296 mL
5 mM 0.5378 mL 2.6892 mL 5.3784 mL 10.7567 mL 13.4459 mL
10 mM 0.2689 mL 1.3446 mL 2.6892 mL 5.3784 mL 6.723 mL
50 mM 0.0538 mL 0.2689 mL 0.5378 mL 1.0757 mL 1.3446 mL
100 mM 0.0269 mL 0.1345 mL 0.2689 mL 0.5378 mL 0.6723 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on GMX1778 (CHS828)

GMX1778 (CHS828) is a potent and specific inhibitor of nicotinamide phosphoribosyltransferase (NAMPT) with a Kd value of 120 nM [1].

NAMPT is an NAD+ biosynthesis enzyme. NAD+ is a cofactor of enzymatic redox reactions that are involved in cellular metabolism, including ATP production. NAD+ is also important in many cellular pathways responsible for gene regulation, calcium homeostasis, genomic integrity, longevity and apoptosis. Cancer cells are significantly dependent on NAD+ for supporting high levels of ATP production for rapid cell proliferation [1].

Treatment with 30 nM GMX1778 for 6 h, extracts of IM-9 cells showed decreased NAD+ and NM levels, compared to cytosolic extracts of untreated cells. These levels continued to decrease throughout the rest of the time course experiment. The most profoundly changed was the metabolite NAD+ level. Between the 6- and 20-h time points, the decline of NAD+ occurred [1].

The NAD+ salvage pathway produces NAD+ using either nicotinic acid (niacin) (NA) or nicotinamide (niacinamide) (NM) as a substrate. NAPRT1 is short for NA phosphoribosyltransferase 1. On xenograft tumors derived from NAPRT1-proficient (HCT-116) and NAPRT1-deficient (HT1080) cell lines in mice, a 24-h iv infusion of GMX1777 at 150 mg/kg or 650 mg/kg produced antitumor activity. A 4-h iv infusion of NA at 120 mg/kg did not adversely affect the antitumor activity of GMX1777 in the NAPRT1-deficient xenograft, but abolished the antitumor activity of GMX1777 against the NAPRT1-proficient HCT-116 cell line [1].

Reference:
[1].  Watson M, Roulston A, Bélec L, et al. The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors. Molecular and cellular biology, 2009, 29(21): 5872-5888.

Featured Products
New Products
 

Description

CHS-828 (GMX1778) is a competitive inhibitor of nicotinamide phosphoribosyltransferase (NAMPT), with an IC50 less than 25 nM. CHS-828 (GMX1778) exerts a cytotoxic effect by decreasing the cellular level of NAD+ and exhibits a potent anticancer activity.

Keywords:

GMX1778 (CHS828),200484-11-3,Natural Products,Nampt, buy GMX1778 (CHS828) , GMX1778 (CHS828) supplier , purchase GMX1778 (CHS828) , GMX1778 (CHS828) cost , GMX1778 (CHS828) manufacturer , order GMX1778 (CHS828) , high purity GMX1778 (CHS828)

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: